Bayer Animal Health has reported a 13.6% increase in revenues for the first three months of 2010. The business unit, part of the Consumer Health segment within Bayer’s HealthCare division, saw sales rise to €259 million ($335.8m) from the €228 million in Q1 2009. The increase was 12.9% after ...
China Animal Healthcare , the Hong Kong–based manufacturer and distributor of livestock and poultry medicines for the Chinese market, has acquired a swine vaccine business.
The company says that subsidiary Shenzhou Pagina-Kang Technology Co has agreed to buy Jianxiang Hemu from its four ...
The US pharmacy company Wedgewood has extended a licensing agreement with Royer Animal Health enabling it to manufacture veterinary cancer treatments using Royer’s drug delivery technology. Wedgewood has an exclusive license to compound implantable beads containing carboplatin using Royer’s Matrix ...
Novartis Animal Health , the veterinary medicines business within the Swiss multinational Novartis medical group, has reported fiscal 2009 revenues of $1.101 billion in local currencies, a 4% increase on the rounded 2008 figure of $1.1bn. Animal Health is part of Novartis' Consumer Health division, ...
Boehringer Ingelheim’s Metacam (meloxicam) 5 mg/ml injectable solution has gained an EU-wide marketing authorization for use as an analgesic to relieve post-operative pain associated with the castration of piglets. The non-steroidal anti-inflammatory drug is now the first product licensed for this ...
